Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database
Han J, Lee J, Jung Y, Kim M, Lee S, Kronbichler A, Tizaoui K, Koyanagi A, Kim E, Song K, Chae H, Yon D, Shin J, Smith L. Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database. Fundamental & Clinical Pharmacology 2024, 38: 780-788. PMID: 38342499, DOI: 10.1111/fcp.12991.Peer-Reviewed Original ResearchConceptsAntineutrophil cytoplasmic antibody (ANCA)-associated vasculitisAdverse drug reactionsAssociated with MMICases of adverse drug reactionsAntithyroid drugsAnti-neutrophil cytoplasmic antibody-associated vasculitisAntibody (ANCA)-associated vasculitisAssociated with high morbidityCase/non-case analysisCases of agranulocytosisAntibody-associated vasculitisAdverse drug effectsAgranulocytosis casesAnti-neutrophilDrug withdrawalAgranulocytosisHigh morbidityCase/non-caseDrug effectsPharmacovigilance databaseIndividual case safety reportsDrug reactionsPropylthiouracilDisproportionality analysisPharmacovigilance studies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply